Balancing act: Tapering mycophenolate mofetil in immune checkpoint inhibitor hepatitis-strategies, outcomes, and risks

doi:10.4292/wjgpt.v16.i4.109485

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (66)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-3)

Sum=60

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=33

Dec 5, 2025 (publication date) through Dec 9, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Gastrointest Pharmacol Ther. Dec 5, 2025; 16(4): 109485
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.109485

Open in New Tab Full Size Figure Download Figure

Figure 1 PRISMA flow diagram on selection of studies. Included records were those that were published in English, on adult populations (> 18 years old), and were relevant to our systematic review. ¹Consider, if feasible to do so, reporting the number of records identified from each database or register searched (rather than the total number across all databases/registers); ²If automation tools were used, indicate how many records were excluded by a human and how many were excluded by automation tools.

Citation: Mujumdar S, Shaikh S, Chan SY, Yekula A, Weinberg DR, Ansari NS, Jerez Diaz D, McPherson SB, Levstik M, Moon AM, Twohig P. Balancing act: Tapering mycophenolate mofetil in immune checkpoint inhibitor hepatitis-strategies, outcomes, and risks. World J Gastrointest Pharmacol Ther 2025; 16(4): 109485
URL: https://www.wjgnet.com/2150-5349/full/v16/i4/109485.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v16.i4.109485